多瑞医药筹划控制权变更 明日开市起停牌

Core Viewpoint - Duori Pharmaceutical (301075) is planning a change in control, leading to a temporary suspension of trading starting September 29, with an expected duration of no more than two trading days [1] Company Summary - The controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd., and the actual controller, Deng Yong, are in discussions regarding the change of control [1] - No formal agreements have been signed yet, and discussions on specific transaction plans and agreements are ongoing [1] - The final implementation and outcome of the transaction remain uncertain, and investors are advised to pay attention to subsequent announcements [1]